Sistas Informing Sistas on Topics About AIDS and Prevention (SISTA-P) (NCT06307028) | Clinical Trial Compass
CompletedNot Applicable
Sistas Informing Sistas on Topics About AIDS and Prevention (SISTA-P)
United States23 participantsStarted 2024-01-08
Plain-language summary
In this project, the investigators will provide a new HIV prevention training and empowerment sessions to Black women in Washington D.C., Atlanta and New Orleans, who are at high risk for getting HIV. This training is tailored to the experience of Black women and seeks to reduce the high HIV transmission rates in the Black community.
Who can participate
Age range
18 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Black women are eligible if you:
* Have sex with men
* Are age 18+
* Live in Washington D.C., Atlanta, GA, or New Orleans, LA
* Are not HIV+
Exclusion Criteria:
* HIV+
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Feasibility of the Intervention Scale
Timeframe: At the time of post-test (after 6 sessions)
2
Acceptability of the Intervention Scale
Timeframe: At the time of post-test (after 6 sessions).
3
Appropriateness of the Intervention Scale
Timeframe: At the time of the post-test (after 6 sessions)
4
Behavioral Intentions (Post-test)
Timeframe: This occurred immediately before session 1 and again after session 6 (42 days after the first session was delivered; 42 days post baseline)
Trial details
NCT IDNCT06307028
SponsorRutgers, The State University of New Jersey